Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib vs Hyoscine for IUD Insertion Pain
NCT03499743Completed
- Sponsor
- Cairo University
- Start
- Apr 2018
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of celecoxib oral solution and hyoscine butylbromide, sponsored by Cairo University. Started Apr 2018; status: completed.
02
Drugs
celecoxib oral solutionhyoscine butylbromide
Beyond the preview
Go deeper on NCT03499743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03499743.